ACTH Resistance: Genes and mechanisms

Endocrine Development

Volumn 24, Issue , 2013, Pages 57-66

  Meimaridou, E ^a   Hughes, C R ^a   Kowalczyk, J ^a   Chan, L F ^a   Clark, A J L ^a   Metherell, L A ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CORTICOTROPIN RECEPTOR; CORTICOTROPIN RECEPTOR MC2R; DNA; MEMBRANE PROTEIN; MINOCHROMOSOME MAINTENANCE DEFICIENT 4 PROTEIN; MRAP PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) TRANSHYDROGENASE; REACTIVE OXYGEN METABOLITE; STEROIDOGENIC ACUTE REGULATORY PROTEIN; UNCLASSIFIED DRUG; ANTIOXIDANT; CORTICOTROPIN; MINICHROMOSOME MAINTENANCE PROTEIN 4;

ACTH RESISTANCE; ARTICLE; CHOLESTEROL TRANSPORT; DNA REPAIR; DNA REPLICATION; ENDOCRINE DISEASE; GENE MUTATION; GENETIC DISORDER; GENOMIC INSTABILITY; GLUCOCORTICOSTEROID DEFICIENCY; HORMONE RESISTANCE; HUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; STEROIDOGENESIS; ADRENAL CORTEX; CORTICOTROPIN DEFICIENCY; LIGAND BINDING; NONHUMAN;

ADRENAL INSUFFICIENCY; ANIMALS; HUMANS; MEMBRANE PROTEINS; METABOLIC NETWORKS AND PATHWAYS; MODELS, BIOLOGICAL; MUTATION; RECEPTOR, MELANOCORTIN, TYPE 2; RECEPTORS, CORTICOTROPIN; SIGNAL TRANSDUCTION; STEROID METABOLISM, INBORN ERRORS; STEROIDS;

EID: 84875474335     PISSN: 14217082     EISSN: 16622979     Source Type: Book Series    
DOI: 10.1159/000342504     Document Type: Article

References (25)

1. Clark AJ, Chan LF, Chung TT, Metherell LA: The genetics of familial glucocorticoid deficiency. Best Pract Res Clin Endocrinol Metab 2009;23: 159-165.
2. Chung TT, Chan LF, Metherell LA, Clark AJ: Phenotypic characteristics of familial glucocorticoid deficiency (FGD) type 1 and 2. Clin Endocrinol (Oxf) 2009;72:589-594.
3. Turan S, Hughes C, Atay Z, Guran T, Haliloglu B, Clark AJ, Bereket A, Metherell LA: An atypical case of familial glucocorticoid deficiency without pigmentation caused by coexistent homozygous mutations in MC2R (T152K) and MC1R (R160W). J Clin Endocrinol Metab 2012;97: E771-E774.
4. Smith R, Healy E, Siddiqui S, Flanagan N, Steijlen PM, Rosdahl I, Jacques JP, Rogers S, Turner R, Jackson IJ, Birch-Machin MA, Rees JL: Melanocortin 1 receptor variants in an Irish population. J Invest Dermatol 1998;111:119-122.
5. Clark AJ, McLoughlin L, Grossman A: Familial glucocorticoid deficiency associated with point mutation in the adrenocorticotropin receptor. Lancet 1993;341:461-462.
6. G?in E, Huebner A, Jaillard C, Faure A, Halaby G, Saka N, Clark AJ, Durand P, B?eot M, Naville D: Linkage of one gene for familial glucocorticoid deficiency type 2 (FGD2) to chromosome 8q and further evidence of heterogeneity. Hum Genet 2002; 111:428-434.
7. Metherell LA, Chapple JP, Cooray S, David A, Becker C, Ruschendorf F, Naville D, Begeot M, Khoo B, Nurnberg P, Huebner A, Cheetham ME, Clark AJ: Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2. Nat Genet 2005;37:166-170.
8. Modan-Moses D, Ben-Zeev B, Hoffmann C, Falik-Zaccai TC, Bental YA, Pinhas-Hamiel O, Anikster Y: Unusual presentation of familial glucocorticoid deficiency with a novel MRAP mutation. J Clin Endocrinol Metab 2006;91:3713-3717.
9. Rumi?H, Metherell LA, Clark AJ, Beauloye V, Maes M: Clinical and biological phenotype of a patient with familial glucocorticoid deficiency type 2 caused by a mutation of melanocortin 2 receptor accessory protein. Eur J Endocrinol 2007;157:539-542.
10. Ak?n L, Kurto?lu S, Kendirici M, Ak?n MA: Familial glucocorticoid deficiency type 2: a case report. J Clin Res Pediatr Endocrinol 2010;2:122-125.
11. Jain V, Metherell LA, David A, Sharma R, Sharma PK, Clark AJ, Chan LF: Neonatal presentation of familial glucocorticoid deficiency resulting from a novel splice mutation in the melanocortin 2 receptor accessory protein. Eur J Endocrinol 2011; 165:987-991.
12. Hughes CR, Chung TT, Habeb AM, Kelestimur F, Clark AJ, Metherell LA: Missense mutations in the melanocortin 2 receptor accessory protein that lead to late onset familial glucocorticoid deficiency type 2. J Clin Endocrinol Metab 2010;95:3497-3501.
13. Webb TR, Clark AJ: Minireview: the melanocortin 2 receptor accessory proteins. Mol Endocrinol 2010;24:475-484.
14. Chung TT, Webb TR, Chan LF, Cooray SN, Metherell LA, King PJ, Chapple JP, Clark AJ: The majority of adrenocorticotropin receptor (melanocortin 2 receptor) mutations found in familial glucocorticoid deficiency type 1 lead to defective trafficking of the receptor to the cell surface. J Clin Endocrinol Metab 2008;93:4948-4954.
15. Metherell LA, Naville D, Halaby G, Begeot M, Huebner A, N?nberg G, N?nberg P, Green J, Tomlinson JW, Krone NP, Lin L, Racine M, Berney DM, Achermann JC, Arlt W, Clark AJL: Non-classic lipoid congenital adrenal hyperplasia masquerading as familial glucocorticoid deficiency. J Clin Endocrinol Metab 2009;94:3865-3871.
16. Miller WL, Bose HS: Early steps in steroidogenesis: intracellular cholesterol trafficking. J Lipid Res 2011;52:2111-2135.
17. Baker BY, Lin L, Kim CJ, Raza J, Smith CP, Miller WL, Achermann JC: Nonclassic congenital lipoid adrenal hyperplasia: a new disorder of the steroidogenic acute regulatory protein with very late presentation and normal male genitalia. J Clin Endocrinol Metab 2006;91:4781-4785.
18. Fl?k CE, Pandey AV, Dick B, Camats N, Fernudez-Cancio M, Clemente M, Gussiny?M, Carrascosa A, Mullis PE, Audi L: Characterization of novel StAR (steroidogenic acute regulatory protein) mutations causing non-classic lipoid adrenal hyperplasia. PLoS One 2011;6:e20178.
19. Sahakitrungruang T, Soccio RE, Lang-Muritano M, Walker JM, Achermann JC, Miller WL: Clinical, genetic, and functional characterization of four patients carrying partial loss-of-function mutations in the steroidogenic acute regulatory protein (StAR). J Clin Endocrinol Metab 2010;95:3352-3359.
20. Parajes S, Kamrath C, Rose IT, Taylor AE, Mooij CF, Dhir V, Gr?zinger J, Arlt W, Krone N: A novel entity of clinically isolated adrenal insufficiency caused by a partially inactivating mutation of the gene encoding for P450 side chain cleavage enzyme (CYP11A1). J Clin Endocrinol Metab 2011;96:1798-1806.
21. Sahakitrungruang T, Tee MK, Blackett PR, Miller WL: Partial defect in the cholesterol side-chain cleavage enzyme P450scc (CYP11A1) resembling nonclassic congenital lipoid adrenal hyperplasia. J Clin Endocrinol Metab 2011;96:792-798.
22. O'Riordan SM, Lynch SA, Hindmarsh PC, Chan LF, Clark AJ, Costigan C: A novel variant of familial glucocorticoid deficiency prevalent among the Irish Traveler population. J Clin Endocrinol Metab 2008;93:2896-2899.
23. Hughes CR, Guasti L, Meimaridou E, Chuang CH, Schimenti JC, King PJ, Costigan C, Clark AJ, Metherell LA: MCM4 mutation causes adrenal failure, short stature, and natural killer cell deficiency in humans. J Clin Invest 2012;122:814-820.
24. Chuang CH, Wallace MD, Abratte C, Southard T, Schimenti JC: Incremental genetic perturbations to MCM2-7 expression and subcellular distribution reveal exquisite sensitivity of mice to DNA replication stress. PLoS Genet 2010;6:pii e1001110.
25. Meimaridou E, Kowalczyk J, Guasti L, Hughes CR, Wagner F, Frommolt P, N?nberg P, Mann NP, Banerjee R, Saka HN, Chapple JP, King PJ, Clark AJL, Metherell LA: Mutations in NNT encoding nicotinamide nucleotide transhydrogenase cause familial glucocorticoid deficiency. Nat Genet 2012;44:740-742.